Stay updated on Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The record describes the Phase 3 KEYNOTE-716 study comparing pembrolizumab with placebo as adjuvant treatment for resected high-risk Stage II melanoma. It also provides study design and outcome details, participant eligibility, locations, and related publications.
    Difference
    100%
    Check dated 2026-11-08T04:40:55.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0. The study record page still displays a 403 error.
    Difference
    0.2%
    Check dated 2026-11-01T01:47:05.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide NIH notice says agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T01:39:32.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T01:28:45.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T01:57:33.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Revision: v3.7.0 was added; sponsor-related and document references were removed from the Study Documents section, reducing the amount of linked materials and sponsor identifiers on the page.
    Difference
    19%
    Check dated 2026-09-20T00:51:14.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial page.